Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2292-2299

  Udayakumar, Thirupandiyur S ^a   Chen, Man Ling ^a   Bair, Elisabeth L ^a   Von Bredow, Dorothea C ^a   Cress, Anne E ^a   Nagle, Raymond B ^a   Bowden, G Timothy ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHYMOTRYPSIN; COMPLEMENTARY DNA; KALININ; MATRIX METALLOPROTEINASE 14; TRYPSIN;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL MIGRATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL ADHESION MOLECULES; CELL MOVEMENT; HUMANS; MALE; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0038713422     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Merker, H. J. Morphology of the basement membrane. Microsc. Res. Tech., 28: 95-124, 1994.
2. Simon-Assmann, P., Kedinger, M., De Arcangelis, A., and Simo, R. V. Extracellular matrix components in intestinal development. Experientia, 51: 883-900, 1995.
3. Lohi, J. Ln-5 in the progression of carcinomas. Int. J. Cancer, 94: 763-767, 2001.
4. Koch, M., Olson, P. F., Albus, A., Jin, W., Hunter, D. D., Brunken, W. J., Burgeson, R. E., and Champliaud, M. F. Characterization and expression of the laminin γ3 chain: a novel, non-basement membrane-associated, laminin chain. J. Cell. Biol., 145: 605-618, 1999.
5. Colognato, H., and Yurchenco, P. D. Form and function: the laminin family of heterotrimers. Dev. Dyn., 218: 213-234, 2000.
6. Hao, J., Jackson, L., Calaluce, R., McDaniel, K., Dalkin, B. L., and Nagle, R. B. Investigation into the mechanism of the loss of laminin 5 (a3β3γ2) expression in prostate cancer. Am. J. Pathol., 158: 1129-1135, 2001.
7. Nagle, R. B., Hao, J., Knox, J. D., Dalkin, B. L., Clark, V., and Cress, A. E. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am. J. Pathol., 146: 1498-1507, 1995.
8. Hao, J., Yang, Y., McDaniel, K. M., Dalkin, B. L., Cress, A. E., and Nagle, R. B. Differential expression of laminin 5 (α 3 β 3 γ 2) by human malignant and normal prostate. Am. J. Pathol., 149: 1341-1349, 1996.
9. Noel, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., and Foidart, J. M. Emerging roles for proteinases in cancer. Invasion Metastasis, 17: 221-239, 1997.
10. Bosman, F. T. The borderline: basement membranes and the transition from premalignant to malignant neoplasia. Microsc. Res. Tech., 28: 216-225, 1994.
11. Flug, M. K., and opf-Maier, P. The basement membrane and its involvement in carcinoma cell invasion. Acta. Anat., 152: 69-84, 1995.
12. Coussens, L. M., and Werb, Z. Matrix metalloproteinase and the development of cancer. Curr. Biol., 3: 895-904, 1996.
13. Hidalgo, M., and Eckhardt, S. G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst., 193: 178-193, 2001.
14. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
15. Hernandez-Barrantes, S., Toth, M., Bernardo, M. M., Yurkova, M., Gervasi, D. C., Raz, Y., Sang, Q. A., and Fridman, R. Binding of active (57-kDa) membrane type 1-matrix metalloproteinase (MTMMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem., 275: 12080-12089, 2000.
16. Nagase, H., and Woessner, J. F., Jr. Matrix metalloproteinases. J. Biol. Chem., 274: 21491-21494, 1999.
17. Knox, J. D., Mack, C. F., Powell, W. C., Bowden, G. T., and Nagle, R. B. Prostate tumor cell invasion: a comparison of orthotopic and ectopic models. Invasion Metastasis, 13: 325-331, 1993.
18. Nagakawa, O., Murakami, K., Yamaura, T., Fujiuchi, Y., Murata, J., Fuse, H., and Saiki, I. Expression of membrane-type 1 matrix metalloproteinase (MTI-MMP) on prostate cancer cell lines. Cancer Lett., 155: 173-179, 2000.
19. Zhang, J., Jung, K., Lein, M., Kristiansen, G., Rudolph, B., Hauptmann, S., Schnorr, D., Loening, S. A., and Lichtinghagen, R. Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate, 50: 38-45, 2002.
20. Upadhyay, J., Shekarriz, B., Nemeth, J. A., Dong, Z., Cummings, G. D., Fridman, R., Sakr, W., Grignon, D. J., and Cher, M. L. Membrane type 1-matrix metalloproteinase (MTI-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin. Cancer Res., 5: 4105-4110, 1999.
21. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K., and Quaranta, V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over Ln-5. J. Cell. Biol., 148: 615-624, 2000.
22. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., and Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of Ln-5. Science (Wash. DC), 277: 225-228, 1997.
23. Rousselle, P., Lunstrum, G. P., Keene, D. R., and Burgeson, R. E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell. Biol., 114: 567-576, 1991.
24. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 68: 850-858, 1996.
25. Eng, J. K., McCormack, A. L., and Yates, J. R., III. J. Am. Soc. Mass Spectrometry, 5: 976-989, 1994.
26. Udayakumar, T. S., Klein, R. D., Maliner, M. S., Nagle, R. B., and Bowden, G. T. Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatdlysin expression by fibroblast growth factors. Int. J. Cancer, 91: 187-192, 2001.
27. Berens, M. E., Rief, M. D., Loo, M. A., and Giese, A. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin. Exp. Metastasis, 12: 405-415, 1994.
28. Amberger, V. R., Hensel, T., Ogata, N., and Schwab, M. E. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res., 58: 149-158, 1998.
29. Knox, J. D., Bretton, L., Lynch, T., Bowden, G. T., and Nagle, R. B. Synthetic matrix metalloproteinase inhibitor. BB-94, inhibits the invasion of neoplastc human prostate cells in a mouse model. Prostate, 35: 248-254, 1998.
30. Gleason, D. F., and Mellinger, G. T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58-64, 1974.
31. Davis, T. L., Cress, A. E., Dalkin, B. L., and Nagle, R. B. Unique expression pattern of the α6β4 integrin and Ln-5 in human prostate carcinoma. Prostate, 46: 240-248, 2001.
32. Ziober, B. L., Lin, C. S., and Kramer, R. H. Laminin-binding integrins in tumor progression and metastasis. Semin. Cancer Biol., 7: 119-128, 1996.
33. Powell, W. C., Knox, J. D., Navre, M., Grogan, T. M., Kittelson, J., Nagle, R. B., and Bowden, G. T. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res., 53: 417-422, 1993.
34. Malinda, K. M., and Kleinman, H. K. The laminins. Int. J. Biochem. Cell Biol., 28: 957-959, 1996.
35. Malinda, K. M., Nomizu, M., Chung, M., Delgado, M., Kuratomi, Y., Yamada, Y., Kleinman, H. K., and Ponce, M. L. Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J., 13: 53-62, 1999.
36. Goldfinger, L. E., Stack, M. S., and Jones, J. C. Processing of Ln-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J. Cell. Biol., 141: 255-265, 1998.
37. Ghosh, S., and Stack, M. S. Proteolytic modification of laminins functional consequences. Microsc. Res. Tech., 51: 238-246, 2000.
38. Baker, S. E., Hopkinson, S. B., Fitchmun, M., Andreason, G. L., Frasier, F., Plopper, G., Quaranta, V., and Jones, J. C. Ln-5 and hemidesmosomes: role of the α 3 chain subunit in hemidesmosome stability and assembly. J Cell Sci., 109: 2509-2520, 1996.
39. Gilles, C., Polette, M., Coraux, C., Tournier, J. M., Meneguzzi, G., Munaut, C., Volders, L., Rousselle, P., Birembaut, P., and Foidart, J. M. Contribution of MT1-MMP and of human Ln-5 γ2 chain degradation to mammary epithelial cell migration. J. Cell. Sci., 114: 2967-2976, 2001.
40. Nakano, A., Pfendner, E., Hashimoto, I., and Uitto, J. Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. J. Investig. Dermatol., 115: 493-498, 2000.
41. McGrath, J. A., Ashton, G. H., Mellerio, J. E., Salas-Alanis, J. C., Swensson, O., McMillan, J. R., and Eady, R. A. Moderation of phenotypic severity in dystrophic and junctional forms of eidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. J. Investig. Dermatol., 113: 314-321, 1999.
42. Pulkkinen, L., Gerecke, D. R., Christiano, A. M., Wagman, D. W., Burgeson, R. E., and Uitto, J. Cloning of the β 3 chain gene (LAMB3) of human laminin 5, a candidate gene in junctional epidermolysis bullosa. Genomics, 25: 192-198, 1995.
43. Vailly, J., Gagnoux-Palacios, L., Dell'Ambra, E., Romero, C., Pinola, M., Zambruno, G., De Luca, M., Ortonne, J. P., and Meneguzzi, G. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene. Ther., 5: 1322-1332, 1998.
44. Robbins, P. B., Lin, Q., Goodnough, J. B., Tian, H., Chen, X., and Khavari, P. A. In vivo restoration of laminin 5 β 3 expression and function in junctional epidermolysis bullosa. Proc. Natl. Acad. Sci. USA, 98: 5193-5198, 2001.